This trial is enrolling individuals with chronic incomplete spinal cord injuries between C4 and L1 to test the safety of a drug (Rimonabant) and its potential effect on walking ability. If included, participants will either take: 1) Rimonabant 5mg per day for 90 days; or 2) a placebo drug for 90 days. Final testing of walking ability will be performed after 90 days; other safety measures will be assessed after 120 days.
Traumatic
Type
Details
- participants will either take 1) Rimonabant 5mg per day for 90 days or 2) a placebo for 90 days. - Final testing of walking ability will be performed after 90 days - Final safety measures will be assessed after 120 days including e.g., adverse events, urine samples, ECG, and questionnaires.
Main benefits
General health
Additional benefits
Arm/hand function
Mental health and psychosocial factors
Pain
Sensory function
Spasticity
Standing/walking/mobility
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more